ArticleSouth Asian journal of cancer2022
Real-World Experience with Nivolumab in Metastatic Renal Cell Carcinoma Patients Who Have Progressed on Prior Therapies: A Single-Center Study from India.
Amit Rauthan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.